Molecular epidemiology of HIV

Indian Journal of Medical Research

Volumn 121, Issue 4, 2005, Pages 333-344

  Kandathil, A J ^a   Ramalingam, S ^a,b   Kannangai, R ^a   David, Shoba ^a   Sridharan, G ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

HIV 1; HIV 2; Sequence diversity; Subtypes

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN;

AFRICA; ASIA; FREQUENCY ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INDIA; MOLECULAR BIOLOGY; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTITUTION; REVIEW; SOUTH AND CENTRAL AMERICA; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; VIRUS CLASSIFICATION; VIRUS RECOMBINATION;

EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HIV; HUMANS; INDIA; PHYLOGENY;

EID: 18844442026     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. UNAIDS/WHO AIDS epidemic update December 2003. Website: www.unaids.org. Accesed on 16th october 2004.
2. Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983; 220 : 865-7.
3. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220 : 868-71.
4. Barin F, M' Boup S, Denis F, Kanki P, Allan JS, Lee TH, et al. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 1985; 2 : 1387-9.
5. Damond F, Apetrei C, Robertson DL, Souquiere S, Lepretre A, Matheron S, et al. Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France. Virology 2001; 280 : 19-30.
6. Machuca A, Soriano V, Gutirrez M, Holguin A, Aguilera A, Caballero E, et al. Human immunodeficiency virus type 2 infection in Spain. The HIV-2 Spanish Study Group. Intervirology 1999; 42 : 37-42.
7. Soriano V, Gomes P, Heneine W, Holguin A, Doruana M, Antunes R, et al. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol 2000; 61 : 111-6.
8. Kulkarni S, Thakar M, Rodrigues J, Banerjee K. HIV-2 antibodies in serum samples from Maharashtra state. Indian J Med Res 1992; 95 : 213-5.
9. Rubsamen-Waigmann H, Maniar J, Gerte S, Brede HD, Dietrich U, Mahambre G, et al. High proportion of HIV-2 and HIV-1/2 double reactive sera in two indian states, Maharashtra and Goa: first appearence of an HIV-2 epidemic along with an HIV-1 epidemic outside of Africa. Zentrabl Bakteriol 1994; 280 : 398-402.
10. Kannangai R, Ramalingam S, Castillo RC, Babu PG, John TJ, Sridharan G, et al. HIV-2 status in southern India. Trans R Soc Trop Med Hyg 1999; 93 : 30-1.
11. Spira S, Wainberg MA, Loemba H, Turner D, Brenner BG. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 2003; 51 : 229-40.
12. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science 1988; 242 : 1171-3.
13. Temin HM. A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993; 90 : 4419-20.
14. Ho DD. HIV-1 dynamics in vivo. J Biol Regul Homeost Agents 1995; 9 : 76-7.
15. Tatt ID, Barlow KL, Nicoll A, Clewley JP. The public health significance of HIV-1 subtypes. AIDS 2001; 15 (Suppl 5) S59-71.
16. Hu W, Vander Heyden N, Ratner L. Analysis of the function of viral protein X (VPX) of HIV-2. Virology 1989; 173 : 624-30.
17. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000, 287 : 607-14.
18. Thomson MM, Perez-Alvarez L, Najera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002; 2 : 461-71.
19. Takebe Y, Kusagawa S, Motomura K. Molecular epidemiology of HIV: tracking AIDS pandemic. Pediatr Int 2004; 46 : 236-44.
20. Subbarao S, Vanichseni S, Hu DJ, Kitayaporn D, Choopanya K, Raktham S, et al. Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res Hum Retroviruses 2000; 16 : 699-707.
21. Shankarappa R, Chatterjee R, Learn GH, Neogi D, Ding M, Roy P, et al. Human immunodeficiency virus type I env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol 2001; 75 : 10479-87.
22. Pollakis G, Abebe A, Kliphuis A, De Wit TFR, Fisseha B, Tegbaru B, et al. Recombination of HIV type 1C (C′ /C″) in Ethiopia: possible link of EthHIV-1C′ to subtype C sequences from the high prevalence epidemics in India and Southern Africa. AIDS Res Hum Retroviruses 2003; 19 : 999-1008.
23. Esteves A, Parreira R, Piedade J, Venenno T, Franco M, Germano de Sousa J, et al. Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. AIDS Res Hum Retroviruses 2003; 19 : 511-7.
24. Peeters M, Sharp PM. Genetic diversity of HIV-1: the moving target. AIDS 2000; 14 (Suppl 3): S129-40.
25. http://www.hiv-web.lanl.gov/cRFs/cRFs.html. Accessed on March 16, 2005.
26. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparaza J, WHO-UNAIDS Network for HIV Isolation and Characterization. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002; 29 : 184-190.
27. McCutchan FE. Understanding the genetic diversity of HIV-1. AIDS 2000; 14 (Suppl 3): S31-44.
28. Takehisa J, Zekeng L, Ido E, Yamaguchi-Kabata Y, Mboudjeka I, Harada Y, et al. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999; 73 : 6810-20.
29. Gao F, Yue L, White AT, Pappas PG, Barchue J, Hanson AP, et al. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature 1992; 358 : 495-9.
30. Gao F, Yue L, Robertson DL, Hill SC, Hui H, Biggar RJ, et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994; 68 : 7433-47.
31. Sharp PM, Robertson DL, Hahn BH.Cross-species transmission and recombination of 'AIDS' viruses. Philos Trans R Soc Lond B Biol Sci 1995; 349 : 41-7.
32. Chen Z, Luckay A, Sodora DL, Telfer P, Reed P, Gettie A, et al. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus infected sooty mangabeys. J Virol 1997; 71 : 3953-60.
33. Holmes EC. On the origin and evolution of the human immunodeficiency virus (HIV). Biol Rev Camb Philos Soc 2001; 76 : 239-54.
34. Yamaguchi J, Devare SG, Brennan CA. Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence. AIDS Res Hum Retroviruses 2000; 16 : 925-30.
35. Damond F, Worobey M, Campa P, Farfara I, Colin G, Matheron S, et al. Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res Hum Retroviruses 2004; 20 : 666-72.
36. van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 1997; 11 : 81-7.
37. Kanki PJ, Hamel DJ, Sankale JL, Hsieh CC, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179 : 68-73.
38. Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, Gadkari DA. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000; 271 : 253-8.
39. Mehendale SM, Bollinger RC, Kulkarni SS, Stallings RY, Brookmeyer RS, Kulkarni SV, et al. Rapid disease progression in human immunodeficiency virus type-1 infected seroconverters in India. AIDS Res Hum Retroviruses 2002; 18 : 1175-9.
40. Kaleebu P, Ross A, Morgan D, Yirell D, Oram J, Rutebemberwa A, et al. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 2001; 15 : 293-9.
41. Yirrell DL, Kaleebu P, Morgan D, Hutchinson S, Whitworth JA. HIV-1 subtype dynamics over 10 years in a rural Ugandan cohort. Int J STD AIDS 2004; 15 : 103-6.
42. Ramalingam S, Kannangai R, Vijayakumar TS, Subramanian S, Abraham OC, Rupali P, et al. Increased number of CCR5+ CD4 T cells among south Indian adults probably associated with low frequency of X4 phenotype of HIV-1 in India. Indian J Med Res 2002; 116 : 90-5.
43. Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, et al. HIV-1 LTR subtype and perinatal transmission. Virology 2001; 287 : 261-5.
44. Oelrichs R. The subtypes of human immunodeficiency virus in Australia and Asia. Sexual Health 2004; 1 : 1-11.
45. Oelrichs RB, Dyer WB, Downie JC, Harvey K, Sullivan JS, Workman C. Inaccurate HIV-1 viral load quantification by three major commercially available methods. AIDS 1999; 13 : 727-40.
46. Swanson P, Soriano V, Devare SG, Hackett Jr J. Comparative performance of three viral load assays on human immunodeficiency virus type 1(HIV-1) Isolates representing group M (Subtypes A to G) and group O: LCx HIV RNA Quantitative, Amplicor HIV-1 MONITOR Version 1.5, and Quantiplex HIV-1 RNA Version 3.0. J Clin Microbiol 2001; 39 : 862-70.
47. Shafer RW. Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev 2002; 15 : 247-77.
48. Kantor R, Katzenstein D. Drug resistance in non-subtype B HIV- 1. J Clin Virol 2004; 29 : 152-9.
49. Tantillo C, Ding J, Jacobo-Molina A, Nanni RG, Boyer PL, Hughes SH, et al. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol 1994; 243 : 369-87.
50. Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, et al. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol 1997; 71 : 8893-8.
51. Delwart EL, Hering B, Rodrigo AG, Mullins JI. Genetic subtyping of human immunodeficiency virus using hetero duplex mobility assay. PCR Meth Appl 1995; 4 : S202-16.
52. Agwale SM, Robbins KE, Odama L, Saekhou A, Zeh C, Edubio A, et al. Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping. J Clin Microbiol 2001; 39 : 2110-4.
53. Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, et al. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J Virol 2000; 74 : 363-70.
54. Taechowisan T, Sutthent R, Louisirirotchanakul S, Puthavathana P, Wasi C. V3 peptide enzyme immunoassay for serotyping HIV-1 infected pregnant Thais. Asian Pac J Allergy Immunol 1996; 14 : 121-3.
55. Couto-Fernandez JC, Morgado MG, Bongertz V, Tanuri A, Andrade T, Brites C, et al. HIV-1 sub typing in Salvador, Bahia, Brazil: a city with African sociodemographic characteristics. J Acquir Immune Defic Syndr 1999; 22 : 288-93.
56. Hussein M, Abebe A, Pollakis G, Brouwer M, Petros B, Fontanet AL, et al. HIV-1 subtype C in commercial sex workers in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 2000; 23 : 120-7.
57. Chanbancherd P, Brown AE, Trichavaroj R, Tienamporn P, Puthakird P, Limpairojn N, et al. Application of dried blood spot specimens for serological subtyping of human immunodeficiency virus type 1 in Thailand. J Clin Microbiol 1999; 37 : 804-6.
58. Gaywee J, Artenstein AW, VanCott TC, Trichavaroj R, Sukchamnog A, Amlee P, et al. Correlation of genetic and serologic approaches to HIV-1 sub typing in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13 : 392-6.
59. Murphy G, Belda FJ, Pau CP, Clewley JP, Parry JV. Discrimination of subtype B and non-subtype B strains of human immunodeficiency virus type 1 by serotyping: correlation with genotyping. J Clin Microbiol 1999; 37 : 1356-60.
60. Plantier JC, Damond F, Souquieres S, Brun-Vezinet F, Simon F, Barin F. V3 serological subtyping of human immunodeficiency virus type 2 infections is not relevant. J Clin Microbiol 2001; 39 : 3803-7.
61. Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin MC, Saragosti S, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998; 4 : 1032-7.
62. Vidal N, Peeters M, Mulunga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, et al. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000; 74 : 10498-507.
63. Yamaguchi J, Bodelle P, Kaptue L, Zekeng L, Gurtler LG, Devare SG, et al. Near full-length genomes of 15 HIV type 1 group O isolates. AIDS Res Hum Retroviruses 2003; 19 : 979-88.
64. Salminen MO, Carr JK, Robertson DL, Hegerich P, Gotte D, Koch C, et al. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol 1997; 71 : 2647-55.
65. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999; 73 : 152-60.
66. Xiang Z, Ariyoshi K, Wilkins A, Dias F, Whittle H, Breuer J. HIV type 2 pathogenecity is not related to subtype in rural Guinea Bissau. AIDS Res Hum Retroviruses 1997; 13 : 501-5.
67. Heredia A, Vallejo A, Soriano V, Silva A, Mansinho K, Fevereiro, et al. Phylogenetic analysis of HIV type 2 strains from Portugal. AIDS Res Hum Retroviruses 1998; 14 : 471-3.
68. Sarr AD, Sankale JL, Gueye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Genetic analysis of HIV type 2 in monotypic and dual HIV infections. AIDS Res Hum Retroviruses 2000; 16 : 295-8.
69. Brennan CA, Yamaguchi J, Vallari AS, Hickman RK, Devare SG. Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma. AIDS Res Hum Retroviruses 1997; 13 : 401-4.
70. Pieniazek D, Ellenberger D, Janini LM, Ramos AC, Nkengasong J, Sassan-Morokro M, et al. Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 1999; 15 : 603-8.
71. http://www.unaids.org/EN/default.asp. Accessed on March 17, 2005.
72. Sahni AK, Prasad VVSP, Seth P. Genomic diversity of human immunodeficiency virus type-1 in India. Int J STD AIDS 2002; 13 : 115-8.
73. Gadkari DA, Moore D, Sheppard HW, Kulkarni SS, Mehendale SM, Bollinger RC. Transmission of genetically diverse strains of HIV-1 in Pune, India. Indian J Med Res 1998; 107 : 1-9.
74. Mandal D, Jana S, Panda S, Bhattacharya S, Ghosh TC, Bhattacharya SK, et al. Distribution of HIV-1 subtypes in female sex workers of Calcutta, India. Indian J Med Res 2000; 112 : 165-72.
75. Ramalingam S, Kannangi R, Vijayakumar TS, Mathai D, Abraham OC, Subramanian S, et al. Subtype and cytokine profiles of HIV infected individuals from south India. Indian J Med Res 2005; 121 : xxx-xx.
76. Jameel S, Zafrullah M, Ahmad M, Kapoor GS, Sehgal S. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS 1995; 9 : 685-90.
77. Grez M, Dietrich U, Balfe P, von Briesen H, Maniar JK, Mahambre G, et al. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol 1994; 68 : 2161-8.
78. Kannangai R, Shaji RV, Ramalingam S, Jesudason MV, Abraham OC, George R, et al. HIV-2 subtype circulating in India (South). J Acquir Immune Defic Syndr 2003; 33 : 219-22.
79. Bhanja P, Mandal DK, Jana S, Bhattacharya SK, Chakrabarti S. Detection and characterization of HIV type 2 in Calcutta, India. AIDS Res Hum Retroviruses 2004; 20 : 101-4.
80. Stamatatos L, Davis D. New insights into protective humoral responses and HIV vaccines. AIDS 2001; 15 (Suppl 5) S105-15.
81. Voss G, Villinger F. Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS. AIDS 2000; 14 (Suppl 3): S153-65.